Pharmaceutical firms sitting on huge cash pile

Korean drug makers remain reluctant to invest. Instead, they are choosing to hold record amounts of cash reserves against the continued uncertain economic outlook and government’s drug related policies, which analysts say will weaken their growth potential.

The cash reserve ratio for all 55 listed firms reached 532 percent last year, according to data released by Yakup.com, a pharmaceutical ...